We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Genfit | EU:GNFT | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.04 | 1.00% | 4.06 | 4.05 | 4.10 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
4.11 | 3.945 | 4.02 | 137,854 | 16:40:00 |
Date | Time | Source | Headline |
---|---|---|---|
13/11/2024 | 21:10 | UKREG | GENFIT fait un point d’actualité sur ses activités à l’occasion de sa.. |
13/11/2024 | 21:10 | UKREG | GENFIT Announces Corporate Updates and Upcoming Participation at The Liver.. |
07/11/2024 | 21:10 | UKREG | GENFIT Reports Third Quarter 2024 Financial Information |
07/11/2024 | 21:10 | UKREG | GENFIT : Information financière du troisième trimestre 2024 |
23/9/2024 | 05:30 | UKREG | GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que.. |
23/9/2024 | 05:30 | UKREG | GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a.. |
19/9/2024 | 20:10 | UKREG | GENFIT : Résultats financiers du premier semestre 2024 et point sur les.. |
19/9/2024 | 20:10 | UKREG | GENFIT Reports First Half-Year 2024 Financial Results and Provides.. |
26/7/2024 | 11:45 | UKREG | GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo®.. |
26/7/2024 | 11:45 | UKREG | GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour.. |
1 Year Genfit Chart |
Intraday Genfit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions